Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Rothenhäusler, HB.
Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders
Wien Med Wochenschr. 2006; 156(23-24): 644-656. Doi: 10.1007/s10354-006-0353-y
PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Rothenhäusler Hans-Bernd
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Since the acquired immune deficiency syndrome (AIDS) was first recognized in 1981, more than 25 million individuals have died from complications of the human immunodeficiency virus (HIV) infection. The introduction of highly active antiretroviral therapy (HAART) in 1995 has resulted in a significantly decreased incidence rate of AIDS in the developed world. As HAART led to considerable improvements in survival for patients with HIV infection, HIV-neurotropically associated neuropsychiatric disorders have become an increasingly important challenge for clinical medicine. This article gives an overview of epidemiology, clinical features, diagnosis, and therapy of HIV-induced cognitive-motor impairments including HIV-associated dementia complex, organic mood disorders and psychosis.
Find related publications in this database (using NLM MeSH Indexing): AIDS Dementia Complex - classification; Acquired Immunodeficiency Syndrome - complications; Anti-HIV Agents - therapeutic use; Antiretroviral Therapy, Highly Active - therapeutic use; Case-Control Studies - therapeutic use; Cognition Disorders - drug therapy; Cohort Studies - drug therapy; Depression - drug therapy; Diagnosis, Differential - drug therapy; Electroencephalography - drug therapy; Female - drug therapy; HIV Infections - complications; Humans - complications; Incidence - complications; Male - complications; Mental Disorders - chemically induced; Mood Disorders - drug therapy; Peripheral Nervous System Diseases - diagnosis; Prevalence - diagnosis; Prospective Studies - diagnosis; Psychotropic Drugs - adverse effects; Reverse Transcriptase Inhibitors - therapeutic use; Risk Factors - therapeutic use